Celltrion
068270.KS
#772
Rank
HK$199.88 B
Marketcap
HK$965.04
Share price
1.34%
Change (1 day)
-5.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: HK$199.88 Billion

As of November 2024 Celltrion has a market cap of HK$199.88 Billion. This makes Celltrion the world's 772th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$199.88 B-23.56%
2023HK$261.48 B84.59%
2022HK$141.65 B-21.65%
2021HK$180.80 B-48.28%
2020HK$349.55 B125.42%
2019HK$155.07 B-20.27%
2018HK$194.48 B-3.29%
2017HK$201.10 B138.56%
2016HK$84.29 B34.57%
2015HK$62.64 B123%
2014HK$28.09 B1.56%
2013HK$27.66 B-17.88%
2012HK$33.68 B18.76%
2011HK$28.36 B5.71%
2010HK$26.82 B162.37%
2009HK$10.22 B64.06%
2008HK$6.23 B4178.81%
2007HK$0.14 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Celltrion was reported to be:

HK$197.41 Billion
by Yahoo Finance info icon info icon
HK$197.41 Billion
by CompaniesMarketCap info icon info icon